Credit Suisse’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$1.99M Buy
51,278
+1,410
+3% +$54.7K ﹤0.01% 1858
2023
Q4
$1.53M Buy
49,868
+1,788
+4% +$55K ﹤0.01% 2054
2023
Q3
$1.07M Buy
48,080
+7,252
+18% +$162K ﹤0.01% 2244
2023
Q2
$877K Buy
40,828
+1,309
+3% +$28.1K ﹤0.01% 2456
2023
Q1
$948K Buy
39,519
+3,028
+8% +$72.6K ﹤0.01% 2347
2022
Q4
$847K Buy
36,491
+10,997
+43% +$255K ﹤0.01% 2442
2022
Q3
$408K Buy
25,494
+197
+0.8% +$3.15K ﹤0.01% 2892
2022
Q2
$448K Buy
25,297
+12
+0% +$213 ﹤0.01% 2896
2022
Q1
$515K Buy
25,285
+1,671
+7% +$34K ﹤0.01% 2938
2021
Q4
$441K Buy
23,614
+1,584
+7% +$29.6K ﹤0.01% 3109
2021
Q3
$435K Sell
22,030
-5,199
-19% -$103K ﹤0.01% 3075
2021
Q2
$644K Buy
27,229
+172
+0.6% +$4.07K ﹤0.01% 2877
2021
Q1
$641K Sell
27,057
-10,387
-28% -$246K ﹤0.01% 2813
2020
Q4
$751K Buy
37,444
+12,757
+52% +$256K ﹤0.01% 2755
2020
Q3
$513K Buy
24,687
+2,108
+9% +$43.8K ﹤0.01% 2670
2020
Q2
$395K Sell
22,579
-5,481
-20% -$95.9K ﹤0.01% 2823
2020
Q1
$458K Sell
28,060
-13,841
-33% -$226K ﹤0.01% 2580
2019
Q4
$863K Buy
41,901
+14,847
+55% +$306K ﹤0.01% 2614
2019
Q3
$311K Sell
27,054
-28,242
-51% -$325K ﹤0.01% 3019
2019
Q2
$727K Buy
55,296
+27,731
+101% +$365K ﹤0.01% 2563
2019
Q1
$418K Buy
27,565
+1,632
+6% +$24.7K ﹤0.01% 2866
2018
Q4
$445K Buy
25,933
+5,029
+24% +$86.3K ﹤0.01% 2799
2018
Q3
$308K Sell
20,904
-8,560
-29% -$126K ﹤0.01% 3041
2018
Q2
$703K Sell
29,464
-46,620
-61% -$1.11M ﹤0.01% 2806
2018
Q1
$1.94M Buy
76,084
+47,000
+162% +$1.2M ﹤0.01% 2085
2017
Q4
$536K Buy
29,084
+10,652
+58% +$196K ﹤0.01% 2915
2017
Q3
$193K Buy
+18,432
New +$193K ﹤0.01% 3452
2017
Q2
Sell
-13,630
Closed -$137K 3431
2017
Q1
$137K Buy
13,630
+1,173
+9% +$11.8K ﹤0.01% 3300
2016
Q4
$194K Buy
12,457
+610
+5% +$9.5K ﹤0.01% 3462
2016
Q3
$228K Sell
11,847
-15,643
-57% -$301K ﹤0.01% 3426
2016
Q2
$326K Buy
+27,490
New +$326K ﹤0.01% 3355